The Food and Drug Administration is ramping up technology adoption, and prioritizing AI and data strategies to ensure safety of new interventions and medical devices, improve workflows and ultimately deliver on its public health mission. Arunan Skandarajah, an FDA Presidential Innovation Fellow who believes in the power of equitable digital tools, discusses how he is innovating FDA’s regulatory processes to drive greater efficiencies.
HealthCast
Season 2
Episode 30
36m listen
How AI, Data Are Boosting FDA’s Regulatory Processes
A Presidential Innovation Fellow is helping the agency improve workflows and ultimately ensure safety of the drugs and treatments it regulates.
-
Arunan Skandarajah Presidential Innovation Fellow FDA
Related Content
-
How Tech Enables Environmental Justice at EPA
The agency wants to eliminate bias and establish new tech standards to reduce greenhouse gas emissions.
39m listen -
The CAIOs Leading Responsible AI Development Across Government
Since the White House's AI executive order, federal agencies are in the process of naming chief artificial intelligence officers.
7m read -
Defense Board to Pitch Solutions for Closing Tech Talent Gaps
Defense Innovation Board members cite need to modernize people management the same way government modernizes technology.
4m read -
Energy Researchers Aim For Holistic Approach to AI Issues
A new center at the Oak Ridge National Laboratory is looking at under-researched areas of AI to better understand how to secure it.
2m read
